Trial · NCT01130532
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period III (Weeks 0-12) | STARTED | 2.5 mg Titrated to 5 mg Tadalafil | 207 | |
| Period III (Weeks 0-12) | STARTED | 5 mg Tadalafil | 207 | |
| Period III (Weeks 0-12) | STARTED | Placebo | 209 | |
| Period III (Weeks 0-12) | STARTED | 5 mg Tadalafil Open-Label Extension | 0 | |
| Period III (Weeks 0-12) | Received at Least 1 Dose of Study Drug | 2.5 mg Titrated to 5 mg Tadalafil | 205 | |
| Period III (Weeks 0-12) | Received at Least 1 Dose of Study Drug | 5 mg Tadalafil | 205 | |
| Period III (Weeks 0-12) | Received at Least 1 Dose of Study Drug | Placebo | 207 | |
| Period III (Weeks 0-12) | Received at Least 1 Dose of Study Drug | 5 mg Tadalafil Open-Label Extension | 0 | |
| Period III (Weeks 0-12) | COMPLETED | 2.5 mg Titrated to 5 mg Tadalafil | 186 | |
| Period III (Weeks 0-12) | COMPLETED | 5 mg Tadalafil | 189 | |
| Period III (Weeks 0-12) | COMPLETED | Placebo | 190 | |
| Period III (Weeks 0-12) | COMPLETED | 5 mg Tadalafil Open-Label Extension | 0 | |
| Period III (Weeks 0-12) | NOT COMPLETED | 2.5 mg Titrated to 5 mg Tadalafil | 21 | |
| Period III (Weeks 0-12) | NOT COMPLETED | 5 mg Tadalafil | 18 | |
| Period III (Weeks 0-12) | NOT COMPLETED | Placebo | 19 | |
| Period III (Weeks 0-12) | NOT COMPLETED | 5 mg Tadalafil Open-Label Extension | 0 | |
| Period IV (Weeks 13-16) | STARTED | 2.5 mg Titrated to 5 mg Tadalafil | 0 | |
| Period IV (Weeks 13-16) | STARTED | 5 mg Tadalafil | 0 | |
| Period IV (Weeks 13-16) | STARTED | Placebo | 0 | |
| Period IV (Weeks 13-16) | STARTED | 5 mg Tadalafil Open-Label Extension | 562 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01130532/flow